Patent details

Basic Information

Publication number:

EP3202413

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP161957766

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MODIFIED PEPTIDES AND THEIR USE FOR TREATING AUTOIMMUNE DISEASES

French Title of Invention:

PEPTIDES MODIFIÉS ET LEUR UTILISATION POUR TRAITER LES MALADIES AUTO-IMMUNES

German Title of Invention:

MODIFIZIERTE PEPTIDE UND DEREN VERWENDUNG ZUR BEHANDLUNG VON AUTOIMMUNKRANKHEITEN

SPC Number:

Dates

Filing date:

13/12/2011

Grant date:

01/08/2018

EP Publication Date:

09/08/2017

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/08/2018

EP B1 Publication Date:

01/08/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

13/12/2018

Expiration date:

13/12/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/07/2018

 

 

Name:

Centre National de la Recherche Scientifique (C.N.R.S.)

Address:

3 rue Michel Ange, 75794 Paris, France (FR)

Name:

ImmuPharma France SA

Address:

5, rue du Rhône, 68100 Mulhouse, France (FR)

Inventor

1

Name:

Muller, Sylviane

Address:

France (FR)

2

Name:

Zimmer, Robert

Address:

France (FR)

3

Name:

Briand, Jean-Paul

Address:

France (FR)

Classification

IPC classification:

A61K 38/04; C07K 7/08;

Publication

European Patent Bulletin

Issue number:

201831

Publication date:

01/08/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/04/2019	Outgoing Correspondence	1